U.S. Chemicals Stock News

With a price-to-earnings (or "P/E") ratio of 9.7x Green Brick Partners, Inc. ( NYSE:GRBK ) may be sending bullish...

With a median price-to-sales (or "P/S") ratio of close to 2.8x in the Medical Equipment industry in the United States...

The Glimpse Group, Inc. ( NASDAQ:VRAR ) shareholders would be excited to see that the share price has had a great...

Anyone interested in Amylyx Pharmaceuticals, Inc. ( NASDAQ:AMLX ) should probably be aware that the Co-Founder, Justin...

We wouldn't blame Snowflake Inc. ( NYSE:SNOW ) shareholders if they were a little worried about the fact that Vivek...

We can readily understand why investors are attracted to unprofitable companies. For example, although...

Over the last year, a good number of insiders have significantly increased their holdings in Neurogene Inc...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Blue Bird fair value estimate is US$94.98 Blue Bird is...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Key Insights Institutions' substantial holdings in Rayonier Advanced Materials implies that they have significant...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Stitch Fix fair value estimate is US$6.57 Stitch Fix is...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...

With a price-to-earnings (or "P/E") ratio of 27x Element Solutions Inc ( NYSE:ESI ) may be sending bearish signals at...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

American Financial Group, Inc.'s ( NYSE:AFG ) dividend will be increasing from last year's payment of the same period...

If you have been watching ThredUp lately, you know it is one of those rare stocks that keeps drawing your attention. Whether you are holding after that massive 1-year surge or you are still weighing your next move, there is a lot to unpack. ThredUp has soared an eye-catching 1111.0% over the last year, with a staggering 568.8% gain year-to-date. Even after a recent 30-day dip of -10.7%, it has still notched a respectable 2.4% gain in the past week. This reminds investors that volatility can...

Ovid Therapeutics recently announced positive topline results from its Phase 1 study of OV329, a next-generation GABA-aminotransferase inhibitor targeting drug-resistant epilepsies, demonstrating significant GABAergic inhibition and strong safety outcomes in 68 healthy volunteers. This clinical milestone signals potential advancement in the treatment of drug-resistant epilepsies and attracted new institutional investors through a substantial private placement. We'll explore how OV329’s early...

Thinking about what to do with Globe Life stock? You are definitely not alone. Friends and clients keep asking whether it is the right time to get in, stay patient, or take some profits. Globe Life’s price has had its share of twists lately, most notably a dip of 4.8% in the last week and 2.1% across the past month. Yet, look a little further back and things get more interesting. The stock’s up a strong 22.6% so far this year and an impressive 30.2% over the last twelve months. That kind of...

On September 24, 2025, Zura Bio Limited adopted an Executive Severance Benefit Plan, outlining compensation for executives if terminated without cause or upon resignation for good reason, especially in the context of a change in control. This move comes as the company, which reported having US$154 million in cash with a reported runway of 3.5 years as of June 2025, faces scrutiny over its increasing cash burn and potential funding needs. We'll examine how concerns around Zura Bio's executive...

If you’re standing at a crossroads deciding what to do with Hanover Insurance Group stock, you’re not alone. The stock has been showing some serious momentum this year, drawing investors’ attention with a steady climb and sparking plenty of conversation around growth prospects. In the past five years, the stock has more than doubled, returning 115.5%, while 2024 alone has already brought an impressive 20.5% gain. Even in the last month, Hanover added 3.6%, suggesting that recent shifts in the...

If you’ve been scanning the markets wondering whether now is the right time to buy, hold, or move on from Alexander & Baldwin, you’re not alone. This stock can puzzle even seasoned investors, especially after a rollercoaster of performance. Over the past five years, Alexander & Baldwin’s price has soared nearly 80%, which is impressive for a real estate-focused name. Those who’ve sat tight since 2021 are still up over 22% despite the flat year-over-year returns, and a slight dip of -0.4% in...

If you’re staring down McGraw Hill’s stock chart this week and feeling a little uncertain, you’re not alone. The stock closed at $11.99 most recently, which might look tempting for bargain hunters, but not without a second glance. Over the past month, shares have slipped by 19.6%, and they are down 12.8% in just the last 7 days. Year to date, there has been a drop of 29.5%. That is some heavy turbulence for any portfolio, and it has plenty of investors asking whether this is a blip or a...

Thinking about what to do with Zurn Elkay Water Solutions stock? You are not alone. Investors have watched this water solutions company steadily climb, with shares up 4.9% in the last 30 days and a whopping 29.9% over the past year. The longer-term numbers are even more eye-catching, showing a return of 96.6% over three years and a stunning 217.9% run across five years. After a quieter week, with the stock up just 0.1%, some might wonder if the stock is catching its breath for another sprint...